Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
about
Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's diseaseHuntingtin in health and diseaseThe Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesisComplex trait analysis of the mouse striatum: independent QTLs modulate volume and neuron number.Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease miceBody composition in premanifest Huntington's disease reveals lower bone density compared to controlsLaquinimod treatment in the R6/2 mouse model.Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell deathNitric oxide and nitric oxide synthase in Huntington's disease.Mitochondria as a therapeutic target for aging and neurodegenerative diseases.Oxidative metabolism in YAC128 mouse model of Huntington's disease.Knock-in mouse models of Huntington's disease.Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice.Neurobiology of rodent self-grooming and its value for translational neuroscienceMitochondrial structural and functional dynamics in Huntington's disease.Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington's disease.Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice.BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors.Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.Age-related length variability of polymorphic CAG repeats.Postnatal regulation of limb proprioception by muscle-derived neurotrophin-3.
P2860
Q24554218-694ED1D6-E832-421D-A165-053BCE68C37CQ24554374-2E1E62F4-6723-4C19-A857-0ABF502F8CC7Q24616907-F1553935-CC10-4DF3-9FB2-6446689B77D7Q24797749-6EE62990-B838-4A08-A648-8A8EF1FB5B51Q30437914-168405AA-6645-4C41-AE67-A3F37358C9DBQ33838303-1F634A6C-BB42-44D6-B987-8E0DE91F3A08Q33890346-0F0AF521-915C-40D2-8A9A-1769E2E702CBQ33949349-2DB59E38-4941-4705-8497-01F66C93A7F1Q34208531-ACC352B3-FA02-4424-80AD-5455A88ED24DQ35807409-A7A45D8C-AECA-4498-BF62-17CCA605D0FCQ35924062-EC844290-2787-44A0-B5AF-A9810FDC6082Q36358874-C859D23A-7075-40DC-AA11-CF9A8F369F13Q36389503-7C999054-C126-427B-A0D9-0D85B3804495Q36825003-3D0185BC-D555-464E-AE05-937296CCDD3CQ37356257-8C6AE7EE-F6CE-44E3-A6C6-67A943513B67Q37530288-D6717470-B054-41A9-B31F-F5CDFE76E79DQ38045212-0C9CEF6A-AEDC-494F-B25F-E02054CD4165Q39035184-C639ED5E-0127-4FBC-B58E-2EAF9F892216Q42416060-934D5831-8F71-441B-81A3-98092F6644A1Q45291563-F528FC60-3855-468F-AA65-A162E336643DQ45349098-86CD3ED6-4618-4ECC-A8EE-A040008B0E57Q46923350-2069BC05-200F-4B6B-9CE0-44869EB613EBQ48312639-47BF322D-A4C8-40AF-872A-5F6DA6B46AE3Q48423508-3159EC42-7F01-4524-8BCF-3B14EF52D3ECQ54160036-50819022-3EAE-4A0A-A279-5789FEE8F40E
P2860
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Transgenic mice expressing mut ...... loss in Huntington's disease.
@ast
Transgenic mice expressing mut ...... loss in Huntington's disease.
@en
type
label
Transgenic mice expressing mut ...... loss in Huntington's disease.
@ast
Transgenic mice expressing mut ...... loss in Huntington's disease.
@en
prefLabel
Transgenic mice expressing mut ...... loss in Huntington's disease.
@ast
Transgenic mice expressing mut ...... loss in Huntington's disease.
@en
P2093
P2860
P356
P1476
Transgenic mice expressing mut ...... loss in Huntington's disease.
@en
P2093
P2860
P304
P356
10.1098/RSTB.1999.0456
P407
P577
1999-06-01T00:00:00Z